MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'doughnut hole'. Sat, 03 Sep 2011 03:02:05 +0100 http://www.medworm.com/index.php?rid=4031501&cid=t_199338_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2010%2F10%2Flilly-vs-astrazeneca-on-covering.html Two pharma companies have responded very differently to recent stories in the press about pharma's "deal" with democrats to help cover the gap ("doughnut hole") in Medicare drug coverage. Whereas Lilly hemmed and hawed and skirted the issue and mainly defended high drug prices (see "Why Price Controls Are Not The Right Answer" and my comments here: "LillyPad Launches Specious Rocket Attack Against Drug Price Control Straw Man" and ), AstaZeneca seized the moment to support the coverage and explain how else it is helping senior citizens pay for their prescription drugs (see "Our Fair Share: Closing the Coverage Gap").[For background, see "Medicare "Doughnut Hole" to Cost Pharma Less Than 1% of US Sales."]Just on the basis of the two blog post titles, I have to give AZ kudos for its positive... Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=4031501 Mon, 04 Oct 2010 17:37:00 +0100 4031501 http://www.medworm.com/index.php?rid=4023137&cid=t_199338_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FTeWjAuI5TVk%2F And so another work will soon draw to a close. How will you spend the weekend? Picking apples? Taking a nap? Staring at the leaves gathering in your yard? For our part, we will watch one of the short people on the football field and take another golfing (miniature golfing, that is). Oh yes, the official Pharmalot mascots need a walk. We hope you have swell plans yourself. Meanwhile, here is the news of the world. And whatever you do this weekend, enjoy and be safe… Medicare Donut Hole Will Be A Boon To Pharma (Bloomberg News) Ex-Mylan Managers Enter Plea (Pittsburgh Post-Gazette) FDA Orders Most Colchicine Pills Off The Market (MedPage Today) Court Dismisses Suit Against Savient For Hiding Data (Associated Press) Eli Lilly Chases New Drugs (The New York Times) Meet The Judge Overseei... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4023137 Fri, 01 Oct 2010 11:38:12 +0100 4023137 http://www.medworm.com/index.php?rid=3994337&cid=t_199338_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2010%2F09%2Flillypad-launches-specious-rocket.html Eli Lilly, the drug company that increased the price of its antidepressant Cymbalta by 13.6% in 2009, is using its new corporate blog (LillyPad) as a launching site for defending high drug prices (see "Why Price Controls Are Not The Right Answer"). This latest post was in response to a Washington Post article that articulated fears that drug companies would increase drug prices to cover the costs of offering Medicare beneficiaries a 50% drug discount when they find themselves caught within the infamous "doughnut hole" (see "Will Drug Companies Increase Drug Prices to Cover Medicare 'Doughnut Hole' Discounts?").Lilly's response -- written by Amy O’Connor, Notre Dame alumna, who "manages the intersections between the political environment and Lilly’s business portfolio" -- interests me o... Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=3994337 Wed, 22 Sep 2010 11:13:00 +0100 3994337 http://www.medworm.com/index.php?rid=3560498&cid=t_199338_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F6PUQzXUi6TE%2F Pontificators are having a field day deciphering healthcare reform and PricewaterhouseCoopers is no exception. The consulting firm has just released a report concluding that, despite expanded coverage that will increase revenue, overall drug sales will decline by 4.3 percent from what they would have been otherwise between 2010 and 2019. The bill increases Medicaid rebates, expands discounts to 340b hospitals, requires Medicare Part D discounts and adds a big fees over 10 years. Specifially, a typical big pharma should see a 4 percent drop in revenue, and a large generic drugmaker should see a 2 percent boost. Meanwhile, a medium-size drugmaker with low government sales should expect only a 1 percent decline, but a large drugmaker with lots of government sales can expect a 7 percent drop. ... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3560498 Thu, 13 May 2010 11:16:46 +0100 3560498 http://www.medworm.com/index.php?rid=1729622&cid=t_199338_134_f&fid=36049&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FDiabetesNotes%2F%7E3%2Flpw8EOBy4N8%2F Here is another reason that we see so many admissions to hospitals due to diabetic complications… the doughnut hole. Just what is this you ask? Medicare beneficiaries were responsible for pay as soon as they incurred costs of $2,400 among pharmacy costs. After a beneficiary then spent $3,850 out of their own pocket- coverage kicked in again. That coverage gap is commonly referred to as the doughnut hole. Mind you this doesn’t apply to low-income seniors who qualify for a subsidy. It was found that 15% of those who hit the doughnut hole stopped taking their medication all together and another 1% cut back on their medication use…while 5% switched medications. So darn scary. Just think what this does to an elderly persons diabetes. We need to come up with solutions to end these ... Diabetes Notes blogs http://www.medworm.com/rss/comments.php?id=1729622 Sun, 24 Aug 2008 00:07:26 +0100 1729622